- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
Sinae Apremilast fabrica, supplementum, Factory
Jiangsu Run'an Pharmaceutical Co, Ltd., subsidiaria omnino possessa de Jiangsu Chiatai Qingjiang Pharmaceutical Co, Ltd., modernus summus tech pharmaceuticus societas specialis in R&D, productionis et venditio fertilitatis ordinandae medicinae et varietatis APIs. Project constructionem mense Novembri 2018 incepit, LIX mu aream obtegens, cum tota obsidione 160 decies Yuan et tota area aedificium 25000 quadratum metrorum.
Praecipua activum medicamentum pharmaceuticum (API) producta: Hydrochloridem Gemcitabinum, Celecoxib, bromhexinum hydrochloridum, Iguratimod, Apremilast, Citrate Tofactinib, Crisaborole, Urapidil Hydrochloride, Sugammadex Natrium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium Bromidum, Finerenone, etc. elit mundi genus facti et productorum gignentium opificem per constantem emendationem et innovationem in technologiarum, et occasiones praeclarum negotium praebent sodalibus nostris per orbem terrarum. Munus nostrum ad praestantes operas emptores nobis permisit ut solidas relationes cum sociis nostris toto orbe extunderet.
- View as
CAS#608141-41-9
Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Apremilast
Cas#608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5
CAS NO. 608141-41-9
Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Apremilast
CAS NO. 608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5
CAS 608141-41-9
Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Apremilast
CAS 608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5
608141-41-9
Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Apremilast
Cas#608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5
TABULA Psoriasis Apremilast
Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Plaque Psoriasis Apremilast
Cas#608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5
(+)-N-［2-［1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl］-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl］acetamide
Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Apremilast
Cas#608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5
(+)-N-［2-［1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl］-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl］acetamide est medicamentum psoriaticum arthritis, psorasis et arthritis psoriatica medicamentum.
Quiescere potes ex officina nostra emere Apremilast in Sinis. Pharmaceutical Run'an professionalis Sinarum Apremilast fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.
